Collegium Pharmaceutical, Inc (COLL): R&D Expense
$0
Year ended 2024-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $0 | n/a | 2025-02-27, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $3.98M | -57.9% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $9.45M | -3.3% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $9.77M | -5.5% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $10.34M | +19.4% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $8.66M | +1.0% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $8.57M | -42.7% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $14.95M | +87.4% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $7.97M | -46.7% | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | $14.96M | +5.7% | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | $14.16M | n/a | 2016-03-18, From 2013-01-01 |